Eli Lilly is set to acquire Morphic Therapeutic for $3.2 billion in cash, securing Morphic’s lead program, MORF-057, a selective…
Browsing: Clinical Updates
Mainz Biomed has announced its submission for FDA Breakthrough Device Designation for its groundbreaking colorectal cancer (CRC) screening test. This…
New research indicates that components of the gut microbiome can accurately distinguish children with autism spectrum disorder (ASD) from neurotypical…
The American College of Gastroenterology (ACG) has issued new guidelines emphasizing the importance of a comprehensive patient workup to differentiate…
A recent study explored whether genetic testing can predict patient responses to Semaglutide, a medication used for diabetes and weight…
An innovative new tool, EndoHacks’ transparent cap, is revolutionizing the removal of food bolus in gastroenterology. This cutting-edge device enhances…
Effectively managing malignancy in patients with Inflammatory Bowel Disease (IBD) requires a comprehensive and proactive approach. The latest guidance from…
Dr. Brent Neuschwander-Tetri discusses the latest AASLD guidance on diagnosing and treating Metabolic Associated Steatotic Liver Disease (MASLD). This new…
A recent article on Medscape explores the potential of circulating tumor DNA (ctDNA) to guide clinical decisions in gastrointestinal cancers.…
Celiac disease, affecting approximately 1% of the US population, is an immune-mediated response to gluten, leading to small bowel mucosa…